Retatrutide, a novel dual stimulator of the GLP-1 binding site and glucose-dependent secreted polypeptide (GIP) binding site , is showing promising results in preliminary clinical studies. Recent https://socialmarkz.com/story11993759/retatrutide-emerging-research-and-possible-medical-roles